BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.

Despite recent progress, significant risks remain, leading me to stay on the sidelines regarding investment in Theravance. Explore more details here.

Learn more about whether ACADIA Pharmaceuticals Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

We recently compiled a list of the 10 Most Undervalued US Stocks to Buy According to Hedge Funds. In this article, we are ...

Q4 2024 Earnings Call Transcript March 6, 2025 Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is ...

AGC Biologics wins award for top CDMO in both the "Biologics - Global" and "Cell and Gene - Global" categories in annual CDMO Leadership Awards.

While the job market is tough for life sciences professionals right now, it won’t always be. Employers must continue striving ...

State of Michigan Retirement System boosted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 16.2% ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...